Estimated read time 2 min read

South Korean pharma giant, Celltrion, initiates share cancellation to enhance value

South Korean pharmaceutical giant Celltrion Inc. has announced its decision to cancel approximately 1 percent of its outstanding shares, a move aimed at bolstering shareholder [more…]

Estimated read time 3 min read

South Korean companies face profitability crunch amid economic challenges

In the face of a challenging economic environment, South Korean companies experienced a decline in sales growth and a narrowing of profitability in the third [more…]